SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1633Bio Relience-They tried to sneak this one in before the Christmas holiday. invitrichardred-12/26/2003
1632Pfizer to Acquire Esperion Therapeutics to Extend Its Research Commitsim1-12/21/2003
1631>>NEW HAVEN, Conn., and HOUSTON, Dec. 19 /PRNewswire-FirstCall/ -- Genaisstuck-12/19/2003
1630>>what do you think then is holding up the price of the stock? >> IIcebrg-12/18/2003
1629thats pretty disappointing. what do you think then is holding up the price of thMadharry-12/18/2003
1628IC14 >>Was this publicly announced someplace?>> It depends on whatIcebrg-12/18/2003
1627<i>Icos has just in classical stealth fashion pulled the plug [on] IC14<Biomaven-12/18/2003
1626>>ICOS by Lilly?>> Icos has just in classical stealth fashion pulleIcebrg-12/18/2003
1625UPDATE - INTERVIEW-Over 20 companies chase Celltech drug Thursday December 18, 1nigel bates-12/18/2003
1624UPDATE - Acambis plays down Baxter sale talk as shares fall Thursday December 11keokalani'nui-12/11/2003
1623Is there any reason why Pfizer shouldn't buy Celltech now they have taken banigel bates-12/5/2003
1622<i>Anyhow, a positive move for the mAb-crowd, I suppose.</i> Cannigel bates-11/21/2003
162112:29 Roche CEO says would consider future acquisitions up to $10-$20 bln -- ReDoc Bones-11/21/2003
1620Deleted (sigh) I changed my mind again. I wonder what companies like MedImmune Icebrg-11/21/2003
1619Lilly munches AMEV for a pretty nice premium: >>INDIANAPOLIS & SAN DItuck-11/21/2003
1618GENE munches privately held GeneSoft, gains products: >>Genome Therapeutituck-11/18/2003
1617Celltech shares up on talk of Serono bid interest <i>A not entirely fancinigel bates-11/10/2003
1616Invitrogen Acquires Sequitur Inc. Tuesday November 4, 3:30 pm ET Proprietary Stnigel bates-11/4/2003
1615Cephalon to buy Cima for $515 mln Protein Design's Q3 loss widens By Ted Gdalroi-11/3/2003
1614Astex announces merger with metaGen Pharmaceuticals GmbH and improves cash positnigel bates-10/31/2003
1613HOT OFF THE WIRE PORTFOLIO NEWS - from Lycos Finance (NASDAQ:CEPH) Cephalon, Indalroi-10/28/2003
1612Acambis left vulnerable after BTG settlement Sunday October 26, 11:55 am ET By nigel bates-10/27/2003
16112004 targets ICOS by Lilly? Evidently Taurel/Lilly has said the following abouIcebrg-10/18/2003
1610perhaps add ceph trms ?dalroi-10/14/2003
1609<i>why you guys think vphm would be an attractive takeover</i> I guBiomaven-10/14/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News